An independent education platform. Built for clarity in a noisy space.

Immortal Peps exists because the peptide and longevity research space is starved of rigorous, primary-source education. We are not a retailer, a clinic, or a forum. We are writers, researchers, and editors — and our only output is content you can verify.

Why we built this

The peptide and biohacking literature has scaled faster than its editorial infrastructure. Forums, social threads, and marketing sites fill the gap left by mainstream science journalism — but they do not cite primary sources, and they routinely conflate animal-model observation with human therapeutic claim.

Immortal Peps was started to fix that. We translate peer-reviewed preclinical and clinical research into readable guides, clearly graded by evidence level, and free from commercial influence. When a compound has only been studied in rodent tendon repair, we say so. When a peptide has Phase 3 data in a specific population, we say so — and we link the paper.

We do not sell compounds. We do not prescribe protocols. We do not endorse supplements. We describe what the literature shows, where the limits are, and where evidence stops.

What we publish

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Compound guides

in-depth profiles covering mechanism, evidence base, key studies, and a transparent summary of where the research currently stands.

Research articles

focused analysis of a specific question, paper, or area of the literature. Always linked to primary sources.

Protocol breakdowns

structured reviews of how compounds are studied together, including the synergy rationale and the caveats.

How we grade evidence

Every compound guide carries an evidence badge that communicates the current strength of available research. Our grading system uses three tiers:

Preclinical

Research is limited to in vitro (cell culture) and/or in vivo (animal model) studies. No peer-reviewed human clinical trials have been published. This is the most common grading for research peptides.

Human Trials

At least one peer-reviewed clinical trial involving human subjects has been published. This does not imply regulatory approval or clinical recommendation — only that human data exists in the literature.

Mixed

Available research includes both preclinical and early-stage human data, but evidence is inconsistent, limited in scope, or conflicting across studies. Further research is needed before conclusions can be drawn.

Evidence grades are reviewed and updated as new research is published. The grade reflects the state of the literature, not our opinion on the compound’s efficacy.

Editorial independence

Our editorial content is never influenced by commercial partners. We do not accept payment for coverage, ranking, or sequencing. Affiliate or referral relationships — if any exist — are clearly disclosed and separated from research content.

Immortal Peps does not currently operate as a commercial enterprise. There are no products on this site. There is no checkout. The platform is funded to enable independent research education, and that funding source is itself disclosed in our editorial standards.

Our standards, in numbers

99%+

Articles

29

Compound profiles

4

Editorial pillars

100%

Batch documented

Read the editorial framework.

Source standards, evidence grading, and the disclosure policies behind every article on this site.